Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira Jacobson

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
American Journal of Clinical Pathology|July 28, 2010
Clinical and biologic importance of F-actin autoantibodies in HCV monoinfected and HCV-HIV coinfected patientsRachel M Hudacko, Gustavo A Alvarez, Andrew H Talal, et al.
Journal of Hepatology|December 8, 2004
Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patientsKeyur Patel, Stuart C Gordon, Ira Jacobson, et al.
Journal of Hepatology|March 10, 2016
Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trialZobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Medicine|February 17, 2017
Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work ProductivityZobair M Younossi, Maria Stepanova, Rafael Esteban, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2019
Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported OutcomesZobair M Younossi, Maria Stepanova, Ira Jacobson, et al.
Clinical Transplantation|May 23, 2020
Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donorsAlex Reyentovich, Claudia G Gidea, Deane Smith, et al.
Hepatitis Research and Treatment|October 25, 2012
Hepatitis C virus: a critical appraisal of new approaches to therapyDavid R Nelson, Donald M Jensen, Mark S Sulkowski, et al.
Journal of Hepatology|March 28, 2017
Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analysesTania M Welzel, Neeru Bhardwaj, Charlotte Hedskog, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 21, 2017
Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without VoxilaprevirZobair M Younossi, Maria Stepanova, Stuart Gordon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2008
Hepatitis C virus: a critical appraisal of approaches to therapyDavid R Nelson, Gary L Davis, Ira Jacobson, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
American Journal of Clinical Pathology|July 28, 2010
Clinical and biologic importance of F-actin autoantibodies in HCV monoinfected and HCV-HIV coinfected patientsRachel M Hudacko, Gustavo A Alvarez, Andrew H Talal, et al.
Journal of Hepatology|December 8, 2004
Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patientsKeyur Patel, Stuart C Gordon, Ira Jacobson, et al.
Journal of Hepatology|March 10, 2016
Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trialZobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Medicine|February 17, 2017
Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work ProductivityZobair M Younossi, Maria Stepanova, Rafael Esteban, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2019
Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported OutcomesZobair M Younossi, Maria Stepanova, Ira Jacobson, et al.
Clinical Transplantation|May 23, 2020
Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donorsAlex Reyentovich, Claudia G Gidea, Deane Smith, et al.
Hepatitis Research and Treatment|October 25, 2012
Hepatitis C virus: a critical appraisal of new approaches to therapyDavid R Nelson, Donald M Jensen, Mark S Sulkowski, et al.
Journal of Hepatology|March 28, 2017
Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analysesTania M Welzel, Neeru Bhardwaj, Charlotte Hedskog, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 21, 2017
Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without VoxilaprevirZobair M Younossi, Maria Stepanova, Stuart Gordon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2008
Hepatitis C virus: a critical appraisal of approaches to therapyDavid R Nelson, Gary L Davis, Ira Jacobson, et al.
Pageof 5